Grantham, Mayo, Van Otterloo & Co (GMO)
CAVM

Grantham, Mayo, Van Otterloo & Co (GMO)’s Cavium, Inc. CAVM Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CAVM Stock Details CAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-340,372
Closed -$29.4M – 628
2018
Q2 		$29.4M Sell
340,372
-325,935
-49% -$26.1M 0.21% 74
2018
Q1 		$52.9M Buy
666,307
+330,333
+98% +$28.8M 0.32% 60
2017
Q4 		$28.2M Buy
+335,974
New +$26M 0.17% 91

Grantham, Mayo, Van Otterloo & Co (GMO)'s CAVM Position: Q3 2018 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Cavium, Inc. (CAVM) in Q3 2018, closing a stake of 340,372 shares — an estimated $29.4M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in CAVM in Q4 2017 and held it in 3 quarters. The position peaked at $52.9M in Q1 2018. 0 funds tracked by Wall St. Rank hold CAVM as of Q3 2018.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Cavium, Inc. position as of Q3 2018 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 340,372 Cavium, Inc. shares in Q3 2018, an estimated $29.4M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Cavium, Inc. in Q4 2017 and held it in 3 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Cavium, Inc. position peaked at $52.9M in Q1 2018.
  • 0 funds tracked by Wall St. Rank held Cavium, Inc. as of Q3 2018.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2018, filed 14 Nov 2018.